Enhanced Recovery and Patient Blood Management in Colorectal Surgery
Launched by OSPEDALE SANDRO PERTINI, ROMA · Jan 27, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Enhanced Recovery and Patient Blood Management in Colorectal Surgery," is examining how following specific care programs can improve recovery and reduce complications after colorectal surgery. Researchers want to see if sticking to these Enhanced Recovery After Surgery (ERAS) and Patient Blood Management (PBM) guidelines can lead to better outcomes for patients, particularly in relation to issues like anastomotic leaks (where the surgical connections between the intestines may not heal properly) and the need for blood transfusions.
To participate in this study, patients should be adults aged 65 and older who are scheduled for certain types of colorectal surgeries, including laparoscopic (minimally invasive) or open surgeries involving reconnections of the intestines. It's important that the surgery is planned in advance, and participants need to agree to be part of the study. Throughout the trial, participants can expect close monitoring and support as they recover from surgery, helping to ensure their safety and wellbeing. This trial is currently recruiting participants, and it aims to gather valuable information that could improve surgical care for many patients in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients submitted to laparoscopic/robotic/open/converted ileo-colo-rectal resection with anastomosis, including planned Hartmann's reversals.
- • 2. American Society of Anesthesiologists' (ASA) class I, II, III or IV
- • 3. Elective or delayed urgency (\> 24 hours from admission) surgery
- • 4. Patients' written acceptance to be included in the study.
- Exclusion Criteria:
- • 1. American Society of Anesthesiologists' (ASA) class V
- • 2. Emergent surgery (≤ 24 hours from admission)
- • 3. Pregnancy
- • 4. Hyperthermic intraperitoneal chemotherapy for carcinomatosis.
About Ospedale Sandro Pertini, Roma
Ospedale Sandro Pertini, located in Rome, is a prominent healthcare institution renowned for its commitment to providing high-quality patient care and advancing medical research. As a clinical trial sponsor, the hospital leverages its state-of-the-art facilities and a multidisciplinary team of experienced healthcare professionals to facilitate innovative research initiatives. Ospedale Sandro Pertini is dedicated to improving therapeutic outcomes through rigorous clinical studies that adhere to the highest ethical standards and regulatory requirements, ensuring the safety and well-being of participants while contributing to the advancement of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Roma, Rm, Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials